Articles of Biotechnology Center

News »

Cuba registers new skin cancer medicine

piel enferma

After 20 years of research and clinical trials, Cuba’s Havana-based Genetic Engineering and Biotechnology Center (CIGB) has developed a new medicine called “Heberferon.” BiologistIraldo Bello, who participated in the process, described the drug which combines interferón “Alfa” and interferón “Gamma” through the use of recombinant technology at the CIGB – as “unique” in the world.